{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T10:58:39Z","timestamp":1787741919954,"version":"build-2784847793"},"reference-count":105,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2018,11,27]],"date-time":"2018-11-27T00:00:00Z","timestamp":1543276800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>The mineralocorticoid hormone aldosterone regulates sodium and potassium homeostasis but also adversely modulates the maladaptive process of cardiac adverse remodeling post-myocardial infarction. Through activation of its mineralocorticoid receptor (MR), a classic steroid hormone receptor\/transcription factor, aldosterone promotes inflammation and fibrosis of the heart, the vasculature, and the kidneys. This is why MR antagonists reduce morbidity and mortality of heart disease patients and are part of the mainstay pharmacotherapy of advanced human heart failure. A plethora of animal studies using cell type\u2013specific targeting of the MR gene have established the importance of MR signaling and function in cardiac myocytes, vascular endothelial and smooth muscle cells, renal cells, and macrophages. In terms of its signaling properties, the MR is distinct from nuclear receptors in that it has, in reality, two physiological hormonal agonists: not only aldosterone but also cortisol. In fact, in several tissues, including in the myocardium, cortisol is the primary hormone activating the MR. There is a considerable amount of evidence indicating that the effects of the MR in each tissue expressing it depend on tissue- and ligand-specific engagement of molecular co-regulators that either activate or suppress its transcriptional activity. Identification of these co-regulators for every ligand that interacts with the MR in the heart (and in other tissues) is of utmost importance therapeutically, since it can not only help elucidate fully the pathophysiological ramifications of the cardiac MR\u2019s actions, but also help design and develop novel better MR antagonist drugs for heart disease therapy. Among the various proteins the MR interacts with are molecules involved in cardiac G protein-coupled receptor (GPCR) signaling. This results in a significant amount of crosstalk between GPCRs and the MR, which can affect the latter\u2019s activity dramatically in the heart and in other cardiovascular tissues. This review summarizes the current experimental evidence for this GPCR-MR crosstalk in the heart and discusses its pathophysiological implications for cardiac adverse remodeling as well as for heart disease therapy. Novel findings revealing non-conventional roles of GPCR signaling molecules, specifically of GPCR-kinase (GRK)-5, in cardiac MR regulation are also highlighted.<\/jats:p>","DOI":"10.3390\/ijms19123764","type":"journal-article","created":{"date-parts":[[2018,11,27]],"date-time":"2018-11-27T12:17:35Z","timestamp":1543321055000},"page":"3764","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Novel Insights into the Crosstalk between Mineralocorticoid Receptor and G Protein-Coupled Receptors in Heart Adverse Remodeling and Disease"],"prefix":"10.3390","volume":"19","author":[{"given":"Barbara M.","family":"Parker","sequence":"first","affiliation":[{"name":"Laboratory for the Study of Neurohormonal Control of the Circulation, Department of Pharmaceutical Sciences (Pharmacology), College of Pharmacy, Nova Southeastern University, Fort Lauderdale, FL 33328, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelby L.","family":"Wertz","sequence":"additional","affiliation":[{"name":"Laboratory for the Study of Neurohormonal Control of the Circulation, Department of Pharmaceutical Sciences (Pharmacology), College of Pharmacy, Nova Southeastern University, Fort Lauderdale, FL 33328, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celina M.","family":"Pollard","sequence":"additional","affiliation":[{"name":"Laboratory for the Study of Neurohormonal Control of the Circulation, Department of Pharmaceutical Sciences (Pharmacology), College of Pharmacy, Nova Southeastern University, Fort Lauderdale, FL 33328, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria L.","family":"Desimine","sequence":"additional","affiliation":[{"name":"Laboratory for the Study of Neurohormonal Control of the Circulation, Department of Pharmaceutical Sciences (Pharmacology), College of Pharmacy, Nova Southeastern University, Fort Lauderdale, FL 33328, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Maning","sequence":"additional","affiliation":[{"name":"Laboratory for the Study of Neurohormonal Control of the Circulation, Department of Pharmaceutical Sciences (Pharmacology), College of Pharmacy, Nova Southeastern University, Fort Lauderdale, FL 33328, USA"},{"name":"Present address: Jackson Memorial Hospital, Miami, FL 33136, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie A.","family":"McCrink","sequence":"additional","affiliation":[{"name":"Laboratory for the Study of Neurohormonal Control of the Circulation, Department of Pharmaceutical Sciences (Pharmacology), College of Pharmacy, Nova Southeastern University, Fort Lauderdale, FL 33328, USA"},{"name":"Present address: Massachusetts General Hospital, Boston, MA 02114, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9817-6319","authenticated-orcid":false,"given":"Anastasios","family":"Lymperopoulos","sequence":"additional","affiliation":[{"name":"Laboratory for the Study of Neurohormonal Control of the Circulation, Department of Pharmaceutical Sciences (Pharmacology), College of Pharmacy, Nova Southeastern University, Fort Lauderdale, FL 33328, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2018,11,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1530\/JOE-14-0471","article-title":"Mineralocorticoid receptors in the heart: Lessons from cell-selective transgenic animals","volume":"224","author":"Young","year":"2015","journal-title":"J. Endocrinol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1056\/NEJMra000050","article-title":"Aldosterone in congestive heart failure","volume":"345","author":"Weber","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1159\/000480652","article-title":"The Role of the Mineralocorticoid Receptor in Inflammation: Focus on Kidney and Vasculature","volume":"46","author":"Belden","year":"2017","journal-title":"Am. J. Nephrol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/nrneph.2013.110","article-title":"Contribution of aldosterone to cardiovascular and renal inflammation and fibrosis","volume":"9","author":"Brown","year":"2013","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1161\/HYPERTENSIONAHA.114.04488","article-title":"Mineralocorticoid receptor activation and mineralocorticoid receptor antagonist treatment in cardiac and renal diseases","volume":"65","author":"Bauersachs","year":"2015","journal-title":"Hypertension"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1097\/01.ASN.0000086472.65806.73","article-title":"Aldosterone in chronic kidney and cardiac disease","volume":"14","author":"Hostetter","year":"2003","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1210\/jc.2013-2049","article-title":"Displacement of cortisol from human heart by acute administration of a mineralocorticoid receptor antagonist","volume":"99","author":"Iqbal","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"T17","DOI":"10.1530\/JOE-17-0119","article-title":"30 years of the mineralocorticoid receptor: Mineralocorticoid receptor activation and specificity-conferring mechanisms: A brief history","volume":"234","author":"Funder","year":"2017","journal-title":"J. Endocrinol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1210\/jc.2003-030373","article-title":"Aldosterone: Direct effects on and production by the heart","volume":"88","author":"White","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"H989","DOI":"10.1152\/ajpheart.00073.2018","article-title":"New roles of aldosterone and mineralocorticoid receptors in cardiovascular disease: Translational and sex-specific effects","volume":"315","author":"Davel","year":"2018","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"R33","DOI":"10.1530\/JME-15-0318","article-title":"Mineralocorticoid regulation of cell function: The role of rapid signalling and gene transcription pathways","volume":"58","author":"Ong","year":"2017","journal-title":"J. Mol. Endocrinol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s10741-016-9591-2","article-title":"Genomic and rapid effects of aldosterone: What we know and do not know thus far","volume":"22","author":"Hermidorff","year":"2017","journal-title":"Heart Fail. Rev."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1146\/annurev-pharmtox-010814-124302","article-title":"Mineralocorticoids in the heart and vasculature: New insights for old hormones","volume":"55","author":"Lother","year":"2015","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1161\/HYPERTENSIONAHA.113.01251","article-title":"Aldosterone and blood pressure regulation: Recent milestones on the long and winding road from electrocortin to KCNJ5, GPER, and beyond","volume":"63","author":"Feldman","year":"2014","journal-title":"Hypertension"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.mce.2011.06.038","article-title":"Aldosterone, mineralocorticoid receptor, and heart failure","volume":"350","author":"Messaoudi","year":"2012","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.freeradbiomed.2012.10.549","article-title":"Blood pressure has only minor influence on aldosterone-induced oxidative stress and DNA damage in vivo","volume":"54","author":"Queisser","year":"2013","journal-title":"Free Radic. Biol. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"H2372","DOI":"10.1152\/ajpheart.00283.2011","article-title":"A role for cardiotrophin-1 in myocardial remodeling induced by aldosterone","volume":"301","author":"Rossignol","year":"2011","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/FJC.0b013e31820088ca","article-title":"Structural, functional, and molecular alterations produced by aldosterone plus salt in rat heart: Association with enhanced serum and glucocorticoid-regulated kinase-1 expression","volume":"57","author":"Miana","year":"2011","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1139\/y05-068","article-title":"CIHR Multidisciplinary Research Group on Hypertension. Role of aldosterone in angiotensin II-induced cardiac and aortic inflammation, fibrosis, and hypertrophy","volume":"83","author":"Neves","year":"2005","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"H1484","DOI":"10.1152\/ajpheart.01000.2010","article-title":"Mineralocorticoid receptor blockade improves diastolic function independent of blood pressure reduction in a transgenic model of RAAS overexpression","volume":"300","author":"Habibi","year":"2011","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.regpep.2009.12.002","article-title":"Role of Rho kinase and oxidative stress in cardiac fibrosis induced by aldosterone and salt in angiotensin type 1a receptor knockout mice","volume":"160","author":"Kagiyama","year":"2010","journal-title":"Regul. Pept."},{"key":"ref_22","first-page":"55","article-title":"Aldosterone increases plasminogen activator inhibitor-1 synthesis in rat cardiomyocytes","volume":"239","author":"Chun","year":"2005","journal-title":"Mol. Cell. Biochem."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S1734-1140(09)70007-6","article-title":"Effects of aldosterone on coronary function","volume":"61","author":"Benard","year":"2009","journal-title":"Pharmacol. Rep."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s11010-013-1672-0","article-title":"Spironolactone inhibits apoptosis in rat mesangial cells under hyperglycaemic conditions via the Wnt signalling pathway","volume":"380","author":"Zhu","year":"2013","journal-title":"Mol. Cell. Biochem."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Kitada, K., Nakano, D., Liu, Y., Fujisawa, Y., Hitomi, H., Shibayama, Y., Shibata, H., Nagai, Y., Mori, H., and Masaki, T. (2012). Oxidative stress induced glomerular mineralocorticoid receptor activation limits the benefit of salt reduction in Dahl salt-sensitive rats. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0041896"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.2215\/CJN.01340209","article-title":"Mineralocorticoid receptor blockers and chronic kidney disease","volume":"4","author":"Jain","year":"2009","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1161\/CIRCULATIONAHA.110.983023","article-title":"Deletion of cardiomyocyte mineralocorticoid receptor ameliorates adverse remodeling after myocardial infarction","volume":"123","author":"Fraccarollo","year":"2011","journal-title":"Circulation"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1161\/HYPERTENSIONAHA.107.100941","article-title":"Immediate mineralocorticoid receptor blockade improves myocardial infarct healing by modulation of the inflammatory response","volume":"51","author":"Fraccarollo","year":"2008","journal-title":"Hypertension"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1161\/HYPERTENSIONAHA.110.163287","article-title":"Ablation of mineralocorticoid receptors in myocytes but not in fibroblasts preserves cardiac function","volume":"57","author":"Lother","year":"2011","journal-title":"Hypertension"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1161\/HYPERTENSIONAHA.112.203158","article-title":"Cardiomyocyte mineralocorticoid receptors are essential for deoxycorticosterone\/salt-mediated inflammation and cardiac fibrosis","volume":"60","author":"Rickard","year":"2012","journal-title":"Hypertension"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1161\/HYPERTENSIONAHA.112.198986","article-title":"Aldosterone-specific activation of cardiomyocyte mineralocorticoid receptor in vivo","volume":"61","author":"Messaoudi","year":"2013","journal-title":"Hypertension"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.yjmcc.2017.12.011","article-title":"Neutrophil Gelatinase-Associated Lipocalin from immune cells is mandatory for aldosterone-induced cardiac remodeling and inflammation","volume":"115","author":"Buonafine","year":"2018","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1161\/HYPERTENSIONAHA.108.114223","article-title":"Corticosteroids and redox potential modulate spontaneous contractions in isolated rat ventricular cardiomyocytes","volume":"52","author":"Rossier","year":"2008","journal-title":"Hypertension"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1210\/en.2009-1375","article-title":"Contribution of mineralocorticoid and glucocorticoid receptors to the chronotropic and hypertrophic actions of aldosterone in neonatal rat ventricular myocytes","volume":"151","author":"Rossier","year":"2010","journal-title":"Endocrinology"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1161\/01.HYP.0000144466.11568.7e","article-title":"Mechanisms for aldosterone and spironolactone-induced positive inotropic actions in the rat heart","volume":"44","author":"Barbato","year":"2004","journal-title":"Hypertension"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1161\/CIRCULATIONAHA.104.503706","article-title":"Conditional mineralocorticoid receptor expression in the heart leads to life-threatening arrhythmias","volume":"111","author":"Benitah","year":"2005","journal-title":"Circulation"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"H2035","DOI":"10.1152\/ajpheart.00552.2010","article-title":"Coronary endothelial dysfunction after cardiomyocyte-specific mineralocorticoid receptor overexpression","volume":"300","author":"Favre","year":"2011","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1291\/hypres.30.427","article-title":"Spironolactone modulates expressions of cardiac mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase 2 and prevents ventricular remodeling in post-infarct rat hearts","volume":"30","author":"Takeda","year":"2007","journal-title":"Hypertens. Res."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1161\/01.HYP.0000203772.78696.67","article-title":"Mineralocorticoid receptor antagonism attenuates cardiac hypertrophy and failure in low-aldosterone hypertensive rats","volume":"47","author":"Nagata","year":"2006","journal-title":"Hypertension"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"6656","DOI":"10.1074\/jbc.M113.519256","article-title":"The mineralocorticoid receptor promotes fibrotic remodeling in atrial fibrillation","volume":"289","author":"Lavall","year":"2014","journal-title":"J. Biol. Chem."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1527-5299.2005.03722.x","article-title":"Mineralocorticoid receptor is overexpressed in cardiomyocytes of patients with congestive heart failure","volume":"11","author":"Yoshida","year":"2005","journal-title":"Congest. Heart Fail."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1161\/01.HYP.0000184640.81730.22","article-title":"Eplerenone inhibits atherosclerosis in nonhuman primates","volume":"46","author":"Takai","year":"2005","journal-title":"Hypertension"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1161\/01.ATV.0000195782.07637.44","article-title":"Aldosterone promotes thrombosis formation after arterial injury in mice","volume":"26","author":"Bodary","year":"2006","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1074\/jbc.M116.739243","article-title":"Mineralocorticoid receptor deficiency in macrophages inhibits atherosclerosis by affecting foam cell formation and efferocytosis","volume":"292","author":"Shen","year":"2017","journal-title":"J. Biol. Chem."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.cjca.2012.04.014","article-title":"Effects of aldosterone on human atherosclerosis: Plasma aldosterone and progression of carotid plaque","volume":"28","author":"Hackam","year":"2012","journal-title":"Can. J. Cardiol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1677\/JME-08-0144","article-title":"Corticosteroid receptors, macrophages and cardiovascular disease","volume":"42","author":"Rickard","year":"2009","journal-title":"J. Mol. Endocrinol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1365-2567.2007.02611.x","article-title":"Glucocorticoids exert opposing effects on macrophage function dependent on their concentration","volume":"122","author":"Lim","year":"2007","journal-title":"Immunology"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"3416","DOI":"10.1210\/en.2011-2098","article-title":"Macrophage mineralocorticoid receptor signaling plays a key role in aldosterone-independent cardiac fibrosis","volume":"153","author":"Bienvenu","year":"2012","journal-title":"Endocrinology"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1161\/HYPERTENSIONAHA.113.01803","article-title":"Endothelial cell mineralocorticoid receptors regulate deoxycorticosterone\/salt-mediated cardiac remodeling and vascular reactivity but not blood pressure","volume":"63","author":"Rickard","year":"2014","journal-title":"Hypertension"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"3350","DOI":"10.1172\/JCI41080","article-title":"Myeloid mineralocorticoid receptor controls macrophage polarization and cardiovascular hypertrophy and remodeling in mice","volume":"120","author":"Usher","year":"2010","journal-title":"J. Clin. Investig."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"191","DOI":"10.4049\/jimmunol.0802886","article-title":"Aldosterone promotes autoimmune damage by enhancing Th17-mediated immunity","volume":"184","author":"Herrada","year":"2010","journal-title":"J. Immunol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1161\/HYPERTENSIONAHA.113.02883","article-title":"Spironolactone decreases DOCA-salt-induced organ damage by blocking the activation of T helper 17 and the downregulation of regulatory T. lymphocytes","volume":"63","author":"Amador","year":"2014","journal-title":"Hypertension"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"T23","DOI":"10.1530\/JOE-17-0060","article-title":"30 years of the mineralocorticoid receptor: Coregulators as mediators of mineralocorticoid receptor signaling diversity","volume":"234","author":"Fuller","year":"2017","journal-title":"J. Endocrinol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jsbmb.2014.04.015","article-title":"Post-translational modifications of the mineralocorticoid receptor: How to dress the receptor according to the circumstances?","volume":"143","author":"Faresse","year":"2014","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/nm.1879","article-title":"Modification of mineralocorticoid receptor function by Rac1 GTPase: Implication in proteinuric kidney disease","volume":"14","author":"Shibata","year":"2008","journal-title":"Nat. Med."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1161\/HYPERTENSIONAHA.115.06054","article-title":"Rac1-mediated activation of mineralocorticoid receptor in pressure overload-induced cardiac injury","volume":"67","author":"Ayuzawa","year":"2016","journal-title":"Hypertension"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"200","DOI":"10.4330\/wjc.v9.i3.200","article-title":"Angiotensin receptor blocker drugs and inhibition of adrenal beta-arrestin-1-dependent aldosterone production: Implications for heart failure therapy","volume":"9","author":"Lymperopoulos","year":"2017","journal-title":"World J. Cardiol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1161\/CIRCRESAHA.113.300308","article-title":"Adrenergic Nervous System in Heart Failure: Pathophysiology and Therapy","volume":"113","author":"Lymperopoulos","year":"2013","journal-title":"Circ. Res."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.2217\/pgs.14.120","article-title":"Pharmacogenetics of cardiac inotropy","volume":"15","author":"Lymperopoulos","year":"2014","journal-title":"Pharmacogenomics"},{"key":"ref_60","first-page":"1209","article-title":"Current and future G protein-coupled receptor signaling targets for heart failure therapy","volume":"7","author":"Dabul","year":"2013","journal-title":"Drug Des. Dev. Ther."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ejphar.2015.05.019","article-title":"GPCR signaling and cardiac function","volume":"763","author":"Capote","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"5825","DOI":"10.1073\/pnas.0811706106","article-title":"An adrenal beta-arrestin 1-mediated signaling pathway underlies angiotensin II-induced aldosterone production in vitro and in vivo","volume":"106","author":"Lymperopoulos","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.jacc.2010.08.635","article-title":"Adrenal beta-arrestin 1 inhibition in vivo attenuates post-myocardial infarction progression to heart failure and adverse remodeling via reduction of circulating aldosterone levels","volume":"57","author":"Lymperopoulos","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1016\/j.jacc.2014.09.070","article-title":"Different potencies of angiotensin receptor blockers at suppressing adrenal \u03b2-Arrestin1-dependent post-myocardial infarction hyperaldosteronism","volume":"64","author":"Lymperopoulos","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"8116","DOI":"10.1038\/srep08116","article-title":"Suppression of adrenal \u03b2arrestin1-dependent aldosterone production by ARBs: Head-to-head comparison","volume":"5","author":"Dabul","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"e00226","DOI":"10.1002\/prp2.226","article-title":"Structure-activity relationship study of angiotensin II analogs in terms of \u03b2-arrestin-dependent signaling to aldosterone production","volume":"4","author":"Valero","year":"2016","journal-title":"Pharmacol. Res. Perspect."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"E1790","DOI":"10.1152\/ajpendo.00708.2006","article-title":"Aldosterone-induced EGFR expression: Interaction between the human mineralocorticoid receptor and the human EGFR promoter","volume":"292","author":"Grossmann","year":"2007","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.bbamcr.2010.02.008","article-title":"Colocalization of mineralocorticoid and EGF receptor at the plasma membrane","volume":"1803","author":"Grossmann","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1096\/fj.09-146985","article-title":"Mineralocorticoid receptor inhibits CREB signaling by calcineurin activation","volume":"24","author":"Grossmann","year":"2010","journal-title":"FASEB J."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.mce.2011.07.019","article-title":"Non-genomic actions of aldosterone: From receptors and signals to membrane targets","volume":"350","author":"Dooley","year":"2012","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1111\/1440-1681.12157","article-title":"Vascular effects of aldosterone: Sorting out the receptors and the ligands","volume":"40","author":"Feldman","year":"2013","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1210\/me.2006-0559","article-title":"Direct binding and activation of protein kinase C isoforms by aldosterone and 17beta-estradiol","volume":"21","author":"Alzamora","year":"2007","journal-title":"Mol. Endocrinol."},{"key":"ref_73","first-page":"805","article-title":"Rapid aldosterone effects on tyrosine phosphorylation in vascular smooth muscle cells","volume":"45","author":"Manegold","year":"1999","journal-title":"Cell. Mol. Biol. (Noisy-le-Grand, France)"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1210\/ME.2014-1410","article-title":"Role of Nongenomic Signaling Pathways Activated by Aldosterone During Cardiac Reperfusion Injury","volume":"29","author":"Ashton","year":"2015","journal-title":"Mol. Endocrinol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.cardfail.2004.03.002","article-title":"Aldosterone directly stimulates cardiac myocyte hypertrophy","volume":"10","author":"Okoshi","year":"2004","journal-title":"J. Card. Fail."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"10877","DOI":"10.1038\/ncomms10877","article-title":"Myocardial pathology induced by aldosterone is dependent on non-canonical activities of G protein-coupled receptor kinases","volume":"7","author":"Cannavo","year":"2016","journal-title":"Nat. Commun."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1161\/01.HYP.0000176588.51027.35","article-title":"C-Src-dependent nongenomic signaling responses to aldosterone are increased in vascular myocytes from spontaneously hypertensive rats","volume":"46","author":"Callera","year":"2005","journal-title":"Hypertension"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1124\/jpet.109.154443","article-title":"Differential effects of p38 mitogen-activated protein kinase and cyclooxygenase 2 inhibitors in a model of cardiovascular disease","volume":"330","author":"Willette","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.mce.2010.04.019","article-title":"Protein kinase D1 modulates aldosterone-induced ENaC activity in a renal cortical collecting duct cell line","volume":"325","author":"McEneaney","year":"2010","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1161\/01.CIR.0000121426.43044.2B","article-title":"Aldosterone, through novel signaling proteins, is a fundamental molecular bridge between the genetic defect and the cardiac phenotype of hypertrophic cardiomyopathy","volume":"109","author":"Tsybouleva","year":"2004","journal-title":"Circulation"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1291\/hypres.31.1811","article-title":"Aldosterone enhances ligand-stimulated nitric oxide production in endothelial cells","volume":"31","author":"Mutoh","year":"2008","journal-title":"Hypertens. Res."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1210\/mend.13.1.0226","article-title":"Modulation of human mineralocorticoid receptor function by protein kinase A","volume":"13","author":"Massaad","year":"1999","journal-title":"Mol. Endocrinol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"49120","DOI":"10.1074\/jbc.M409746200","article-title":"cAMP-dependent protein kinase regulates ubiquitin\u2013proteasome-mediated degradation and subcellular localization of the nuclear receptor coactivator GRIP1","volume":"279","author":"Hoang","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"4373","DOI":"10.1096\/fj.12-209924","article-title":"Differential ubiquitylation of the mineralocorticoid receptor is regulated by phosphorylation","volume":"26","author":"Faresse","year":"2012","journal-title":"FASEB J."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.cmet.2013.10.005","article-title":"Mineralocorticoid receptor phosphorylation regulates ligand binding and renal response to volume depletion and hyperkalemia","volume":"18","author":"Shibata","year":"2013","journal-title":"Cell Metab."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"317","DOI":"10.2174\/1874467211205030001","article-title":"GRK2 and Beta-Arrestins in Cardiovascular Disease: Established and Emerging Possibilities for Therapeutic Targeting","volume":"5","author":"Harvey","year":"2012","journal-title":"Curr. Mol. Pharmacol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.pharmthera.2011.08.001","article-title":"G protein-coupled receptor kinases: More than just kinases and not only for GPCRs","volume":"133","author":"Gurevich","year":"2012","journal-title":"Pharmacol. Ther."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"186","DOI":"10.2174\/138161212799040510","article-title":"GRK2 inhibition in heart failure: something old, something new","volume":"18","author":"Lymperopoulos","year":"2012","journal-title":"Curr. Pharm. Des."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/s11936-009-0033-5","article-title":"Future g protein-coupled receptor targets for treatment of heart failure","volume":"11","author":"Rengo","year":"2009","journal-title":"Curr. Treat. Opt. Cardiovasc. Med."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.yjmcc.2010.08.014","article-title":"GRK2 as a novel gene therapy target in heart failure","volume":"50","author":"Rengo","year":"2011","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"539","DOI":"10.4330\/wjc.v7.i9.539","article-title":"Adrenal G protein-coupled receptor kinase-2 in regulation of sympathetic nervous system activity in heart failure","volume":"7","author":"McCrink","year":"2015","journal-title":"World J. Cardiol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/nm1553","article-title":"Adrenal GRK2 upregulation mediates sympathetic overdrive in heart failure","volume":"13","author":"Lymperopoulos","year":"2007","journal-title":"Nat. Med."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.cell.2017.03.047","article-title":"Structural and Functional Analysis of a \u03b22-Adrenergic Receptor Complex with GRK5","volume":"169","author":"Komolov","year":"2017","journal-title":"Cell"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"10169","DOI":"10.1128\/MCB.24.23.10169-10179.2004","article-title":"G protein-coupled receptor kinase 5 contains a DNA-binding nuclear localization sequence","volume":"24","author":"Johnson","year":"2004","journal-title":"Mol. Cell. Biol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"12457","DOI":"10.1073\/pnas.0803153105","article-title":"Uncovering G protein-coupled receptor kinase-5 as a histone deacetylase kinase in the nucleus of cardiomyocytes","volume":"105","author":"Martini","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.phrs.2016.05.008","article-title":"The expanding GRK interactome: Implications in cardiovascular disease and potential for therapeutic development","volume":"110","author":"Hullmann","year":"2016","journal-title":"Pharmacol. Res."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.mce.2004.12.004","article-title":"Enhancement of beta-adrenergic cAMP-signaling by the mineralocorticoid receptor","volume":"231","author":"Christ","year":"2005","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_98","first-page":"A12236","article-title":"Differential Roles of GRK2 and GRK5 in Cardiac Aldosterone Signaling Suggest GRK5-Mediated Cardio-protection Against Mineralocorticoids","volume":"136","author":"Lymperopoulos","year":"2017","journal-title":"Circulation"},{"key":"ref_99","unstructured":"Lymperopoulos, A. (2018). unpublished work."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/nm1750","article-title":"A GRK5 polymorphism that inhibits beta-adrenergic receptor signaling is protective in heart failure","volume":"14","author":"Liggett","year":"2008","journal-title":"Nat. Med."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/1478-811X-11-64","article-title":"GRK2 blockade with \u03b2ARKct is essential for cardiac \u03b22-adrenergic receptor signaling towards increased contractility","volume":"11","author":"Salazar","year":"2013","journal-title":"Cell Commun. Signal."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1097\/CCM.0000000000001678","article-title":"Autonomic Dysfunction in Critical Illness: ObNOX(2)ious (Baro)reflex Upregulation of G Protein-Coupled Receptor Kinase-2 Lets the Heart Down","volume":"44","author":"Lymperopoulos","year":"2016","journal-title":"Crit. Care Med."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/s11897-014-0247-z","article-title":"Pathophysiology of sepsis-related cardiac dysfunction: Driven by inflammation, energy mismanagement, or both?","volume":"12","author":"Drosatos","year":"2015","journal-title":"Curr. Heart Fail. Rep."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"17818","DOI":"10.1073\/pnas.0804446105","article-title":"The G-protein-coupled receptor kinase 5 inhibits NF\u03baB transcriptional activity by inducing nuclear accumulation of I\u03baB \u03b1","volume":"105","author":"Sorriento","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"451","DOI":"10.4155\/fmc.12.216","article-title":"Targeting protein-protein interactions within the cyclic AMP signaling system as a therapeutic strategy for cardiovascular disease","volume":"5","author":"Lee","year":"2013","journal-title":"Future Med. Chem."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/19\/12\/3764\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T15:32:29Z","timestamp":1760196749000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/19\/12\/3764"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,27]]},"references-count":105,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["ijms19123764"],"URL":"https:\/\/doi.org\/10.3390\/ijms19123764","relation":{"has-preprint":[{"id-type":"doi","id":"10.20944\/preprints201811.0389.v1","asserted-by":"object"}]},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,27]]}}}